Navigation Links
Pre Implantation Genetic Haplotyping to Identify 6,000 Inherited Diseases

A new technique was developed to test for inherited disease which would in the near future offer better and healthier babies //. The British fertility clinic says that this new procedure would offer hundreds of couples hope and can test for nearly 6,000 diseases. Even testing for diseases which does not have specific mutation can be detected using this technique. Diseases such as Duchenne's muscular dystrophy (DMD) and some forms of cystic fibrosis can be detected by examine every embryo created for a couple through IVF.

Now clinics can be aware of the X-linked diseases and can take precautionary measures to discard the affected embryos. This leads to wastage of fewer embryos. Professor Peter Braude of King's College London, who was involved in the research, says that this technique can cherry pick healthy embryos for women at risk of passing on inherited diseases. The most common disease that goes unnoticed or is very difficult to detect in the early stage are DMD and Cystic Fibrosis. Statistics show that about 100 boys are born with DMD in Britain daily whose average life expectancy is 17 years. The research is to be presented at the annual meeting in Prague of the European Society of Human Reproduction and Embryology.

The technique is called preimplantation genetic haplotyping. It was first done by Ali al-Hellani, a Saudi Arabian fertility specialist. But it was modified later Pamela Renwick at Guy's hospital genetics centre and Prof Braude, who runs a fertility centre at Kings College, London. The test basically relies on the extraction of one of eight cells from a three-day-old embryo. Then the DNA is extracted from the cell which undergoes the process of multiple displacement amplification to replicate the DNA. Then they blood samples from family members, including at least one person affected by the disease is collected and the DNAs are compared. It is possible to identify the region of a chromosome that is responsible for the disease. Th
'"/>




Page: 1 2

Related medicine news :

1. Cochlear Implantation Increases Meningitis Risk
2. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
3. Genetic influence in menopause
4. Genetics and cholesterol levels
5. Genetics helps in attacking cancer
6. Genetic disorder related with sleep patterns
7. Genetic innovation
8. Genetic tests for cancer
9. Genetic indicates memory
10. Genetic mutation to the fountain of youth discovered
11. Genetic differences found between Male and Female brains
Post Your Comments:
(Date:12/2/2008)...Newswire/ -- diaDexus, Inc. today,announced that ...mat of the,PLAC Test for Lp-PLA2. This automated ... a wide range of clinical chemistry analyzers, was...tration (FDA) in December 2007. diaDexus also,ann...st to Europe. , The PLAC Test is the only b...
(Date:12/2/2008)...t a symposium today hosted by Johns,Hopkins Univ...archers presented,the latest research in brain pl...cience into technology to improve lives. Henry Mah...vidence that cognitive intervention developed by,...brain,s ability to,reorganize itself throughout l...
(Date:12/2/2008)...ewswire/ -- Are you unhappy with your smile but ar...ailable? , , The Pennsylvania Dental Associ...ptions exist to improve your smile. Your dentist c... determine a suitable option to help restore your ...tal options. , , , , Tooth whi...
(Date:12/2/2008)...ed for 3.5 percent of high school athletes, injuri... to examine rare injuries and conditions of U.S. h...uries, dental injuries, neck and cervical injuries...t in high morbidity, costly surgeries and treatmen... associated with the highest rate of rare injuries...
Breaking Medicine News(10 mins):Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2
...riggered by viral cold are common in preschoolers....since the frequency disappears by school age. //Th...r oral steroids at the first sign of an attack. Bu...ive is controversial. The research shows a course...
...be a major improvement for HIV patients in less-de...sess a patient's response to HIV medication.// HIV... This treatment is now becoming available in Afric...etermine the CD4 cell count are needed. A low CD4 ...
...to help acne patients. A new study highlights the ...is is important because this skin disease can lead...b and sometimes even suicide. Doctors from London ...ate facial acne. Thirty-one of the patients receiv...
...is year’s meeting of the American Society of Thera...ment //of external beam radiation may be what it t...ers that have spread to the bone. More than 160 ho... States and Canada were involved in a study of abo...
Other Medicine News:
(Date:12/2/2008)... Horizon Therapeutics, Inc., a,pr...unced that two pivotal,Phase 3 trials evaluating ...1,met all primary endpoints. HZT-501, a novel, p...ing ibuprofen and famotidine, demonstrated a,stat...f non-steroidal,anti-inflammatory drug (NSAID)-in...
(Date:12/1/2008)...ICAGO, Dec. 2 A study h... a new technique for imaging the breast, is not af...nal status, two factors that limit the effectivene...ncer. Results will be presented today at the annua...rica (RSNA). , , "The ability of PEM to de...
(Date:12/1/2008)...RNewswire/ -- S*BIO Pte Ltd today announced the in...a potent and orally-active JAK2 inhibitor, in lead... chronic idiopathic myelofibrosis (CIMF). , ,...nd tolerability of SB1518 in patients with CIMF an...se 1 part of the study will assess the safety prof...
(Date:12/1/2008)... the Prox1 gene is a two-way switch that, if turne...programmed so that they lose their identity and be...MEMPHIS, Tenn., Dec. 1 ...al have discovered that a certain differentiated c...t requires the constant expression of a gene calle...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3After Effects 3A Giving Back Is Good for You 19422 1After Effects 3A Giving Back Is Good for You 19422 2Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke 5419 1Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke 5419 2Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke 5419 3Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke 5419 4Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke 5419 5Targeted therapy plus chemotherapy may pack 1 2 punch against melanoma 19417 1Targeted therapy plus chemotherapy may pack 1 2 punch against melanoma 19417 2AUA 2008 3A Global warming may lead to increase in kidney stones disease 19414 1
...IDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCel.... Beer, President and,Chief Executive Officer of V...ivities and product pipeline at the C.E. Unterberg...on Tuesday, July,10, 2007 at 3:00 p.m. at the Mand...webcast of the presentation will be available on,t...
...ESTER, Mass., Jun 27, 2007 (PrimeNewswire via COMT...ion (Nasdaq:GNBT), the,leader in drug delivery for...e mouth, announced today that it will be making th...g of the European,Society of Pediatric Endocrinolo...rget="_blank" href=,"http://www.espe2007.org/">www...
Other Medicine Technology:Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 2Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 3
... integrated technology and service--mobile,outpati...heartbeat, ECG monitoring, analysis and response, ...y focused on helping physicians diagnose and treat...in diagnosing and treating arrhythmia. Delays can ...
...rmance temperature controlled shaker which accommo...eed and incubation time are fully programmable via...ed on the LCD in real time. Microprocessor-control... provide uniform incubation with less than 0.6 C v...
The iEMS Incubator/Shaker HT is designed for extended temperatures. Thus, the iEMS Incubator/Shaker HT is ideal for applications such as DNA hybridization and primer extension assays. iEMS Incubator/
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -
Medicine Products: